Aptilon announces the filing of its financial reports and the upcoming filing of its proxy information circular for the year 2011 and 2012
MONTREAL, Dec. 27, 2013 /CNW Telbec/ - Aptilon Corporation ("Aptilon" or the "Company") (NEX: APZ.H), today announced that it had filed its proxy information circular for the fiscal periods ended December 31, 2011 and 2012 and that it had filed its financial reports for the year ended December 31, 2012 and the quarters ended March 31, June 30 and September 30, 2013 on SEDAR.
Filing of financial reports
The Company has filed on SEDAR its audited financial statements and Management Discussion and Analysis report ("MD&A") for the year ended December 31, 2012 as well as its unaudited financial statements and MD&A for the periods ended March 31, 2013, June 30, 2013 and September 30, 2013. Complete financial statements and MD&A are available on SEDAR at www.sedar.com.
With these filings, the Company is now up-to-date with all of its filing requirements. The Company will now undertake the process of lifting the cease trade order on its securities.
Filing of proxy information circular and annual meeting
The proxy information circular for the fiscal periods ended December 31, 2011 and 2012 has been produced and sent for printing and will be filed on SEDAR and mailed on December 30, 2013. As announced in a previous press release, the Company's annual meeting will be held on Friday, January 24, 2014.
About Aptilon Corporation
Aptilon enables pharmaceutical, pharmaceutical marketing companies, digital advertising agencies and medical device companies to effectively reach, message, connect and interact with US physicians and healthcare professionals via multiple access channels. Its innovative service offerings provide targeted impressions and interactions through permission-based email, targeted on-line ad-serving, and mobile app advertising channels. Top pharmaceutical companies, agencies and respected healthcare organizations have adopted Aptilon's solutions to target, engage and interact with leading healthcare practitioners. For more information, visit www.dmdconnects.com .
This news release contains forward-looking information. These statements relate to future events or future performance and reflect management's current expectations and assumptions. Such forward-looking statements reflect management's current beliefs and are based on information currently available to management of Aptilon. A number of factors could cause actual events, performance or results to differ materially from the events performance and results discussed in the forward-looking statements. These forward-looking statements are made as of the date hereof and Aptilon does not assume any obligation to update or revise them to reflect new events or circumstances.
Neither NEX, the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE Aptilon HoldingsFor further information:
514-422-0777 ext. 229